{"filings":[{"id":95065,"accession_number":"0001140361-26-015921","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Tilray Brands files routine legal exhibit; no material change to operations","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filing relates to Registration Statement No. 333-290806.","Exhibits include legal opinion and consent from DLA Piper LLP (US).","No financial results, guidance, or operational updates provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95064,"accession_number":"0001140361-26-014692","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Tilray acquires UK medical platform Lyphe; files $180M ATM for beverage expansion","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired Lyphe Group, a UK medical cannabis clinic/pharmacy; dispensed ~150K units, treated 16K+ patients; expected accretive in 2027.","Filed ATM equity program of up to $180M to invest in global beverage platform; managed by Jefferies, TD Securities, Roth Capital.","BrewDog (acquired six weeks ago) stabilizing; expects cash-flow positive in 2027; investing in brand and brewpub modernization.","Plans to launch Hi*Ball Energy in UK in May; evaluating US medical cannabis rescheduling and CMS pilot program."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95063,"accession_number":"0001140361-26-014638","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tilray issues 1.88M shares to exchange $12M in convertible notes due 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 1,879,696 common shares in private debt-for-equity exchange for $12M principal of 5.20% Convertible Senior Notes due June 15, 2027.","Notes carried 5.20% coupon; transactions occurred between April 1 and April 8, 2026.","Shares issued under Section 3(a)(9) exemption; no commission or remuneration paid for soliciting exchanges.","Exchange reduces outstanding convertible debt by $12M while increasing common share count by ~1.9M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95062,"accession_number":"0001171843-26-002136","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2026-04-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray Brands Q3 FY2026 revenue $207M record; intl cannabis +73%; buys BrewDog ~£40M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q3 net revenue of $207M, up 11% organic YoY; gross profit $55M, up 6% YoY.","International cannabis net revenue grew 73% YoY; flower sales volume +100% YoY.","Canadian adult-use and medical cannabis combined revenue up 8% YoY; #1 cannabis position in Canada.","Post-quarter-end, acquired BrewDog for ~£40M cash, expanding craft beverage platform globally.","Balance sheet: $265M cash and marketable securities, net cash ~$3.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":633740000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107863,"accession_number":"0001437749-26-006389","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["1.01","2.01","8.01","9.01"],"status":"ready","headline":"Tilray Brands acquires BrewDog assets for £33M; eyes $200M annual revenue from acquisition","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired BrewDog's global IP, UK brewing ops, and 11 brewpubs for £33M (~$44.1M) via pre-pack administration.","Acquired assets expected to generate ~$200M annual net revenue and ~$6-$8M adjusted EBITDA in FY2027.","Combined global beverage platform projected at ~$500M; total Tilray annualized revenue ~$1.2B.","Separate negotiations ongoing for BrewDog assets in US and Australia, expected to close in ~30 days.","BrewDog brand includes Punk IPA, Hazy Jane, Wingman, Elvis Juice, Dead Pony Club."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107862,"accession_number":"0001171843-26-000146","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray Brands Q2 FY2026 revenue record $218M; net cash $30M; reaffirms EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Net revenue $218M, a record quarterly; international medical cannabis revenue increased 36% YoY.","Ended quarter with $292M cash and marketable securities; net cash position of approximately $30M.","Canadian adult-use cannabis revenue grew 6% YoY; Tilray Pharma achieved record quarterly revenue.","Reaffirmed full-year adjusted EBITDA guidance; Chairman cites disciplined execution and long-term value.","U.S. federal cannabis rescheduling expected to unlock new market opportunity for Tilray Medical expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":427008000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124261,"accession_number":"0001437749-25-036448","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-11-26T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"Tilray announces 1-for-10 reverse stock split effective Dec 1, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split ratio one-for-ten; shares outstanding reduce from 1.16B to ~116M.","Effective 4:01 p.m. ET Dec 1; trading split-adjusted under TLRY begins Dec 2.","Cost savings target: up to $1M annually on meeting-related expenditures.","No fractional shares issued; cash in lieu of fractional interests.","Pacific Stock Transfer acting as paying agent; ownership percentage unchanged except for rounding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124260,"accession_number":"0001437749-25-035739","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-11-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tilray shareholders reject board declassification; say-on-pay passes with ~70%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Re-elected John Herhalt as Class I director: 85.5M for, 23.4M against, 326.9M broker non-votes.","Ratified PwC as auditor: 402.9M for (92.5% of votes cast).","Advisory say-on-pay passed with 72.9M for (68.7% of votes cast, excluding broker non-votes).","Governance Changes Proposal (board declassification, remove-for-cause) failed; 93.6M for but needed majority of outstanding shares, blocked by 326.9M broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124259,"accession_number":"0001437749-25-035455","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Tilray files 8-K with investor presentation; no specific new facts in filing text","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Investor presentation dated Nov 17, 2025 made available on Tilray's IR website.","Presentation content not reproduced in filing; no new financial figures or guidance provided.","Presentation furnished under Regulation FD; not filed and not incorporated by reference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124258,"accession_number":"0001171843-25-006368","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-10-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray Brands Q1 FY2026 net revenue $210M, net income $1.5M, EBITDA +9%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $209.5M (+5% YoY); net income $1.5M vs net loss $34.7M prior year.","Adjusted EBITDA $10.2M (+9% YoY); FY2026 outlook reaffirmed at $62M-$72M.","Cannabis net revenue $64.5M (+5%); Canadian adult-use gross revenue +12%, #1 market share.","Cash $265M, net debt $4M; cash used in ops improved $34M to -$1.3M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":209501000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140939,"accession_number":"0001140361-25-034569","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-09-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Tilray files legal opinion for Registration Statement; no material news","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed opinion of DLA Piper LLP (US) in connection with Registration Statement No. 333-267788.","No financial results, guidance, or other operational updates provided.","Filing is procedural; no impact on business operations or outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140938,"accession_number":"0001171843-25-004746","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray Q4/FY2025: net loss $1.27B on $2.1B impairment; guides FY2026 EBITDA $62-72M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2025 net revenue $821.3M (+4% YoY); Q4 net revenue $224.5M (down 2% from $229.9M).","Q4 net loss $1.27B includes $1.4B non-cash goodwill impairment; adjusted net income $20.2M.","Cannabis gross margin improved to 44% in Q4 (vs 40%); international cannabis revenue up 71% Q4.","Debt reduced ~$100M; cash+marketable securities $256M; net debt/EBITDA 0.3x.","FY2026 adjusted EBITDA guidance $62M-$72M (13-31% growth vs FY2025 $55.0M)."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":821309000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158707,"accession_number":"0001437749-25-021037","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-06-23T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tilray issues 12.6M shares in exchange for $5M of 5.20% Convertible Notes due 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 12,591,816 common shares to retire $5M principal of 5.20% Convertible Senior Notes due June 1, 2027.","Transaction was with an unrelated third-party noteholder; no commissions or solicitation fees paid.","Shares issued under Section 3(a)(9) of the Securities Act, exempt from registration.","Exchange reduces outstanding convertible debt by $5M and adds ~1.7% dilution to existing shareholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158706,"accession_number":"0001140361-25-022089","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tilray shareholders approve reverse stock split up to 1-for-20","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved amendment to allow reverse stock split at ratio between 1:10 and 1:20; 251M for, 182M against.","Board retains discretion to set exact ratio within range or to abandon the split entirely.","Adjournment proposal also approved (269M for, 158M against) to allow further solicitation if needed.","Approximately 1.01 billion shares outstanding as of record date April 15, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158705,"accession_number":"0001140361-25-015720","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tilray exchanges $9.4M convertible notes for 19M shares in private deals","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued 19,034,603 common shares in exchange for $9.4M aggregate principal of 5.20% Convertible Senior Notes due June 2027.","Transactions occurred between April 9-21, 2025; exempt under Section 3(a)(9) of the Securities Act.","Debt-for-equity swap reduces outstanding notes by $9.4M but adds approximately 19M shares outstanding.","No commissions or remuneration were paid for soliciting the exchanges."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158704,"accession_number":"0001437749-25-012217","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-04-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Tilray proposes reverse stock split (1:10 to 1:20) at special meeting June 10, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting of stockholders set for June 10, 2025 to vote on reverse stock split.","Reverse split ratio range 1-for-10 to 1-for-20, exact ratio set by Board of Directors.","Purpose: comply with Nasdaq continued listing requirements and attract institutional investors.","Expected cost savings of over $1 million annual run rate from the reverse split.","Debt reduced ~$76M in FY2025; net debt to TTM Adj. EBITDA <1.0x; cash >$248M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":158703,"accession_number":"0001171843-25-002081","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-04-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray Q3 net revenue $186M; adjusted EBITDA $9M; cannabis margin up 800bps; debt reduced $71M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $185.8M vs $188.3M prior year; constant currency ~$193M; SKU rationalization hit $13.2M.","Net loss $(793.5)M from ~$700M non-cash impairment; adjusted net loss $(2.9)M vs adjusted net income $0.9M.","Cannabis gross margin 41% (+800 bps); segment revenue $54.3M vs $63.4M on international redirect and pause in vapes/pre-rolls.","Beverage alcohol revenue $55.9M (up $1.2M); gross margin 36% (+200 bps).","Debt reduced $71M, including $58M convertible notes; $248M cash/securities; net debt/EBITDA <1x; revises FY2025 guidance to $850-900M."],"consensus_eps_estimate":-0.2295,"consensus_eps_actual":-1.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":596774000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177101,"accession_number":"0001437749-25-009162","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-03-25T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Tilray Brands gets 180 days to cure Nasdaq minimum bid price deficiency","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on March 25, 2025 for non-compliance with $1.00 minimum bid price rule.","Has until September 21, 2025 to close at $1.00 or more for 10 consecutive business days.","If not cured, may transfer to Nasdaq Capital Market for an additional 180-day compliance period.","Company will monitor bid price and evaluate options, including a potential reverse stock split."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177100,"accession_number":"0001437749-25-006857","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tilray to issue up to 23M shares in exchange for $14.6M convertible notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Up to 23M shares issued in private exchange for $14.6M principal of 5.20% Convertible Notes due June 2027.","Debt-for-equity swap executed with unrelated parties; no commissions paid.","Reduces $14.6M debt but dilutes existing shareholders; shares unregistered under Section 3(a)(9)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177099,"accession_number":"0001437749-25-005242","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-02-26T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Tilray subsidiary refinances CAD $53M term loan to CIBC; extends maturity to 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aphria Diamond Inc. entered a CAD $53M credit agreement with CIBC on Feb 21, 2025.","Proceeds repaid CAD $48.17M outstanding under prior BMO-led agreement due Nov 2025.","New term loan matures Feb 21, 2028; quarterly principal payments of CAD $2M begin Aug 2025.","Interest at 1-month Term CORRA plus 1.75% margin, adjustable quarterly based on leverage.","Covenants: fixed charge coverage >=1.25x, total funded debt <=2.75x; Tilray limited guarantee capped at CAD $60M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177098,"accession_number":"0001437749-25-003171","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-02-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Tilray subsidiary Aphria settles Canadian class action for CAD 30M; no admission of liability","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Settled for CAD 30M (US 21M), far below original CAD 875M claim; dismissal with prejudice.","Includes dismissal of four related individual lawsuits on same allegations.","Aphria's portion CAD 8.5M already accrued; no negative earnings impact; D&O insurance covers most.","Court approval hearing scheduled for March 2025.","Settlement does not constitute admission of liability or wrongdoing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177097,"accession_number":"0001140361-25-003428","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tilray to issue up to 21M shares in exchange for $22M in convertible notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issues up to 21M common shares for $22M aggregate principal of 5.20% Convertible Senior Notes due 2027.","Transactions executed privately under Section 3(a)(9) exemption from January 28 to February 5, 2025.","Reduces debt by $22M, lowering future interest obligations on the 5.20% notes.","Dilution impact: up to 21M new shares, ~3% of current outstanding (based on ~700M shares)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177096,"accession_number":"0001171843-25-000152","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2025-01-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray Brands Q2 revenue up 9% to $211M; gross profit +29%; reaffirms FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $211M (record Q2), +9% YoY; gross margin 29% vs 24% prior year.","Net loss $(85)M includes $75M non-cash items; adj net loss $(2)M, adj EPS $(0.00).","Beverage segment +36% to $63M; int'l cannabis +25%; wellness +13%; cannabis flat at $66M.","Project 420 synergy plan achieved $17M of $25M target; reaffirms FY2025 revenue guidance $950M-$1B.","Adjusted EBITDA $9M vs $10M prior year, impacted by $1.8M SKU rationalization cost."],"consensus_eps_estimate":-0.238,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":410994000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193880,"accession_number":"0001437749-24-037950","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-12-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tilray shareholders approve increase in authorized common shares to 1.426B from 1.208B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders voted 223.3M For, 153.5M Against, 6.5M Abstain on increasing authorized common stock.","Authorized shares raised from 1,208,000,000 to 1,426,000,000, a potential dilution of 218M shares.","The proposal passed at the reconvened 2024 annual meeting on December 19, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193879,"accession_number":"0001437749-24-037479","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-12-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Tilray Brands appoints Steven M. Cohen as Class III director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed effective Dec. 8, 2024, as Class III director with term expiring at 2027 annual meeting.","Mr. Cohen is independent under Nasdaq rules and currently interim CEO of AYR Wellness Inc.","Previously served as Chief Administrative Officer and General Counsel of MacAndrews & Forbes and as Secretary to NY Governor Cuomo.","Will receive standard non-employee director compensation and enter into Tilray's indemnification agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193878,"accession_number":"0001437749-24-036395","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-12-02T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Delaware court grants summary judgment for Tilray in proxy vote lawsuit","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Court held Tilray correctly used majority-of-votes-cast standard for authorized share proposals; granted summary judgment for Tilray and directors.","Lawsuit alleged incorrect voting standard and fiduciary breaches; all claims dismissed.","Adjourned portion of 2024 annual meeting re Authorized Shares Proposal set for Dec 19, 2024 at 11:00 am EST (virtual).","Tilray filed supplemental proxy disclosures regarding court ruling and voting standard."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193877,"accession_number":"0001437749-24-035954","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-11-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Tilray annual meeting: authorized shares proposal adjourned, governance changes rejected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["David Hopkinson and Thomas Looney elected as Class III directors; Jodi Butts term ended.","Ratification of PWC as independent auditor approved with ~342M for, ~27M against.","Authorized shares proposal (increase from 1.2B to 1.4B shares) adjourned to Dec 19 pending Delaware court decision.","Governance changes proposal (declassify board, remove cause-only removal) failed with ~83M for vs ~18M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193876,"accession_number":"0001140361-24-045431","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Tilray faces shareholder class action challenging authorized share vote standard","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Lawsuit filed Oct 31, 2024 in Delaware Chancery claims proxy statements improperly used votes-cast standard instead of majority-of-outstanding shares for share increases.","Plaintiff seeks to enjoin Nov 21, 2024 vote on 2024 Authorized Shares Proposal (increase from 1.198B to 1.416B shares).","Company argues 2023 authorized increase (208.6M for, 85.2M against) was valid under DGCL §242(d) and ISS recommends 2024 proposal.","If plaintiff prevails, 2023 increase from 980M to 1.198B shares could be invalid, affecting capital structure and acquisition flexibility.","Tilray intends to defend vigorously; management needs additional authorized shares for strategic objectives including M&A."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193875,"accession_number":"0001437749-24-032999","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Tilray amends credit facility to consent to Molson Coors craft beer acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Fourth Amendment consents to Mack Acquisition of six craft beer brands from Molson Coors.","EBITDA addback of up to $2M for Nov 2024 quarter, $1.75M for Feb 2025 quarter for Mack negative EBITDA.","New Restructuring Costs addback capped at 10% of prior year EBITDA, tied to permitted acquisitions.","Additional guarantors and first-lien security interests in acquired assets granted to lenders.","Loan parties reaffirm obligations; all conditions precedent for amendment effectiveness satisfied."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193874,"accession_number":"0001171843-24-005585","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-10-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray Q1 revenue $200M (+13%), net loss narrows; beverage alcohol up 132%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $200M (+13% YoY); gross margin 30% (+500 bps) to $59.7M.","Net loss improved to ($34.7M) from ($55.9M); EPS ($0.04) vs ($0.10) prior year.","Adjusted EBITDA $9.3M vs $10.7M; adjusted EPS loss ($0.01) vs ($0.04).","Beverage alcohol revenue $56M (+132% YoY); cannabis revenue $61.2M; distribution $68.1M.","German medical cannabis flower revenue grew 50% following legalization."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":200044000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210205,"accession_number":"0001140361-24-041261","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-09-17T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Tilray acquires $23.8M promissory note from DDH; issues 13.2M shares as consideration","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Acquired $23.8M promissory note from Double Diamond Holdings (DDH) payable by Aphria Diamond.","Issued 13,217,588 shares of common stock as consideration to DDH.","DDH is a joint venturer with Tilray's subsidiary Aphria Inc. in Aphria Diamond.","Shares issued under Regulation S exemption; no underwriter or commissions paid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210204,"accession_number":"0001171843-24-004218","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-07-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray FY2024 revenue up 26% to $789M, debt cut $291M, adjusted EBITDA $60.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $788.9M (+26% YoY); Q4 revenue $229.9M (+25%).","Adjusted EBITDA increased 37% in Q4 to $29.5M; FY2024 adjusted EBITDA $60.5M.","Reduced net convertible debt by $291M in FY2024; cash & securities $260.5M.","Cannabis net revenue $272.8M (+24%); beverage-alcohol net revenue $202.1M (+113%).","Net loss narrowed to $222.4M from $1.4B; adjusted net income $6.2M vs $0.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":788942000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228486,"accession_number":"0001140361-24-026595","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-05-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Tilray Brands launches $250M ATM equity program to fund acquisitions, targeting U.S. cannabis rescheduling","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["May offer and sell up to $250M of common stock through TD Securities and Jefferies in at-the-market offerings.","Net proceeds intended to fund strategic and accretive acquisitions, not general working capital.","Company aims to capitalize on expected U.S. cannabis rescheduling and expansion opportunities.","Sales will be made at prevailing market prices; no obligation to sell any shares.","Existing shelf registration statement (Form S-3) effective since October 2022; prospectus supplement filed May 17, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228485,"accession_number":"0001140361-24-025828","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-05-14T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tilray exchanges $19.8M of 5.25% convertible notes for 13.1M shares","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued up to 13.1M shares of common stock to an unrelated party in exchange for $19.8M aggregate principal of 5.25% Convertible Senior Notes due June 2024.","After the exchange, no 2024 Convertible Notes remain outstanding.","Shares issued in reliance on Section 3(a)(9) exemption; no commission or remuneration paid.","Transaction reduces debt by eliminating the convertible notes, adding dilution of approximately 13.1M shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228481,"accession_number":"0001140361-24-025944","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K/A","filed_at":"2024-05-14T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tilray converts $19.8M of 2024 convertible notes to 13.1M shares; only $330K notes remaining","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Expects to issue up to 13.1M shares of common stock in exchange for $19.8M aggregate principal of 5.25% Convertible Senior Notes due June 1, 2024.","After exchange, only $330,000 in principal amount of the 2024 Convertible Notes remain outstanding (down from $20.13M pre-transaction).","Shares issued in reliance on Section 3(a)(9) exemption; no commission paid for solicitation.","Transaction with an unrelated party; reduces near-term debt maturity exposure on June 1, 2024 notes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228484,"accession_number":"0001140361-24-024630","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["3.02"],"status":"ready","headline":"Tilray to issue up to 15.2M shares in exchange for $24M of convertible notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Between April 24 and May 6, 2024, Tilray entered private debt-for-equity exchanges with unrelated parties.","Up to 15.2 million common shares will be issued for $24 million aggregate principal of 5.25% Convertible Senior Notes due June 1, 2024.","Shares issued under Section 3(a)(9) exemption; no commission or remuneration paid for the exchange.","Exchange reduces outstanding debt by $24M but increases diluted share count by up to 15.2M shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228483,"accession_number":"0001140361-24-023601","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Tilray acquires $10.9M promissory note from JV partner, pays 6.1M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Tilray acquired a $10,883,496 promissory note payable by Aphria Diamond from Double Diamond Holdings.","Consideration was 6,148,868 shares of Tilray common stock issued to DDH under Regulation S.","DDH is a joint venture partner with Tilray's subsidiary Aphria Inc. in Aphria Diamond.","Shares issued outside the U.S. to non-U.S. persons; no underwriter or commissions involved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228482,"accession_number":"0001171843-24-001910","cik":1731348,"company_name":"Tilray Brands, Inc.","ticker":"TLRY","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Tilray Q3 revenue up 30% to $188M; adjusts FY EBITDA guidance to $60-63M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $188.3M (+30% YoY); beverage-alcohol revenue surged 165% to $54.7M on craft acquisitions.","Net loss narrowed to $105M ($0.12 per share) vs $1.2B loss a year ago; adjusted EBITDA fell to $10.2M from $13.3M.","Cannabis revenue up 33% to $63.4M; international cannabis growth 44% YoY; #1 market share in Canada and Germany.","FY2024 adjusted EBITDA guidance lowered to $60-63M; no longer expects positive adjusted free cash flow for FY2024.","Reduced convertible debt by $50.7M in Q3, $41.9M post-quarter; liquidity $226M (cash + marketable securities)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":559060000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":676361916.0648649,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}